Travere Therapeutics Inc (TVTX)
EBITDA Margin
0.98%
TTM · Period ending:
TVTX EBITDA Margin
Latest reported0.98%period ending
Latest reported0.98%period ending
TVTX TTM EBITDA Margin (-12221.06% → 0.98%)
TTM ebitda margin
High-resolution chart · PNG
TVTX ebitda margin history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Margin |
|---|---|
| 0.9771% | |
| 7.1873% | |
| 4.528% | |
| -5.181% | |
| -32.2444% | |
| -61.4968% | |
| -113.9801% | |
| -144.6057% | |
| -184.8129% | |
| -231.1474% | |
| -189.0249% | |
| -166.6679% | |
| -175.3535% | |
| -139.1137% | |
| -134.3596% | |
| -126.3967% | |
| -81.3103% | |
| -68.7216% | |
| -58.4307% | |
| -91.8395% | |
| -93.8872% | |
| -90.7733% | |
| -73.1945% | |
| -28.2442% | |
| -37.6861% | |
| -45.782% | |
| -61.1459% | |
| -48.9413% | |
| -61.6667% | |
| -55.8766% | |
| -45.69% | |
| -51.4411% | |
| -31.572% | |
| -27.3404% | |
| -24.9592% | |
| -26.7773% | |
| -36.0524% | |
| -33.917% | |
| -29.8533% | |
| -54.6822% | |
| -43.4958% | |
| -42.7708% | |
| -53.2397% | |
| -32.3941% | |
| -59.3075% | |
| -201.4051% | |
| -378.4781% | |
| -750.0155% | |
| -1,563.7288% | |
| -19,545.0487% | |
| -12,221.0645% |